Otisville: controlled medication accrual, 1/1/2025-3/31/2025 per IAA 943, VA contract 36W79720D0001.
Ended Awarded Last action
- Contract number
- 15B21125F00000059
- Awardee
-
Mckesson Corporation UEI S1RUKWWRYFL6 Part of Mckesson Corporation
- Awarding agency
-
Federal Correctional Institution Otisville
Correctional Facilities, Department of Justice
- Obligated
- $35,005
Award facts
- Contract value 100% obligated
- $35,005.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irving, TX 75039, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,826 | |
| Funding Only Action | -$25,000 | |
| Funding Only Action | -$75,000 | |
| Funding Only Action | $84,980 | |
| Funding Only Action | -$2,000 | |
| Original award | $55,851 |
About this award
McKesson Corporation, a leading pharmaceutical distribution and healthcare services provider headquartered in Irving, Texas, has been awarded a delivery order by the Federal Correctional Institution Otisville under an Interagency Agreement (IAA 943) for controlled medication accrual services. The contract, valued at $35,005.22 on a firm fixed-price basis, runs from January 1, 2025 through March 31, 2025 and represents a non-competed award with no set-aside designation. Performance will be executed in Irving, Texas, with the funding provided by the Department of Justice through its Bureau of Prisons operations. This delivery order falls within McKesson's established role as a prime pharmaceutical supplier to federal correctional facilities, consistent with the company's extensive portfolio of federal contract awards supporting the Bureau of Prisons' controlled and non-controlled medication procurement requirements.
This award reflects McKesson's ongoing strategic relationship with the Bureau of Prisons for pharmaceutical supply chain management across the federal correctional system. The company's significant federal presence includes multiple indefinite delivery vehicles, notably a $25.5 million Blanket Purchase Agreement with the Department of Homeland Security for medical, dental, and surgical supplies, as well as a Medical/Surgical Prime Vendor agreement with the Department of Veterans Affairs. The controlled medication accrual contract represents routine procurement of pharmaceutical inventory to support Otisville's correctional healthcare operations, demonstrating McKesson's continued capability to deliver critical medical products to federal detention facilities nationwide.
Quick answers
Who was awarded contract 15B21125F00000059?
15B21125F00000059 was awarded to Mckesson Corporation by Federal Correctional Institution Otisville (Correctional Facilities) on January 1, 2025.
How much is contract 15B21125F00000059 worth?
The government has obligated $35,005 on 15B21125F00000059.
Is contract 15B21125F00000059 an order under another contract?
Yes. 15B21125F00000059 is a delivery order under 36W79720D0001, an indefinite delivery contract.
Was contract 15B21125F00000059 competed?
The extent of competition for 15B21125F00000059 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award